Excellent post; the research here is top quality. Having worked directly with life science and pharmaceutical companies, I agree that this represents a massive market opportunity. Isomorphic Labs seems built to succeed and capitalize on a highly lucrative demand. That said, I am reserving final judgment until clinical testing begins. Until then, the thesis remains largely hypothetical. Still, this is an area where AI holds immense promise, and it could be genuinely life changing if human trials go well.
Excellent post; the research here is top quality. Having worked directly with life science and pharmaceutical companies, I agree that this represents a massive market opportunity. Isomorphic Labs seems built to succeed and capitalize on a highly lucrative demand. That said, I am reserving final judgment until clinical testing begins. Until then, the thesis remains largely hypothetical. Still, this is an area where AI holds immense promise, and it could be genuinely life changing if human trials go well.
Thank you so much for the kind words!
I am very happy I spoke with a number of experts in the field, super eye opening!
The clinical trials are what most people are waiting for, the valuation might just be 10x higher if the trials work.
Let's hope for society that they go well!